🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)

Recruitingn/aAges 18 Years - anyAllUniversity Hospital of Cologne
NCT06911099 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This investigator-initiated, multicenter, international, retrospective registry aims to investigate outcomes of patients with atrial functional mitral regurgitation, as treated in clinical routine.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * functional mitral regurgitation * left ventricular ejection fraction ≥50% Exclusion Criteria: * age under 18 years * known regional wall movement disorders
💊

What it tests

  • Not listed
📍

Where

22 sites
Montefiore Medical Center
The Bronx, United States
St. Michael's Hospital
Toronto, Canada
Bordeaux University Hospital
Bordeaux, France
University Hospital Center of Nantes
Nantes, France
LMU Klinikum
Munich, Germany
University Hospital Cologne
Cologne, Germany
HDZ Bad Oeynhausen
Bad Oeynhausen, Germany
Heart Center Bonn
Bonn, Germany

…and 14 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy